- Home
- ONCY vs BLNK Comparison
ONCY vs BLNK Comparison
Compare ONCY & BLNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ONCY | BLNK |
|---|---|---|
| Founded | 1998 | 2009 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 94.0M | 94.6M |
| IPO Year | 2002 | 2008 |
Fundamental Metrics
Financial Performance| Metric | ONCY | BLNK |
|---|---|---|
| Price | $1.00 | $0.66 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 7 |
| Target Price | ★ $6.00 | $2.13 |
| AVG Volume (30 Days) | 1.7M | ★ 1.8M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.94 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $126,197,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $17.87 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.33 | $0.63 |
| 52 Week High | $1.51 | $2.65 |
Technical Indicators
Market Signals| Indicator | ONCY | BLNK |
|---|---|---|
| Relative Strength Index (RSI) | 49.75 | 40.19 |
| Support Level | $0.87 | $0.65 |
| Resistance Level | $1.13 | $0.74 |
| Average True Range (ATR) | 0.10 | 0.04 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 55.11 | 37.50 |
Price Performance
Historical ComparisonAbout ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About BLNK Blink Charging Co.
Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns a majority of revenue from U.S.A.